ALTEOGEN revenue and financials
₩259,500.00Change from previous close: −2.08%Absolute change: −₩5,500.00
In the fiscal year ended December 2025, ALTEOGEN reported revenue of ₩215.86B (+109.87% year over year). Net income was ₩141.67B, a net margin of 65.6%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +109.87%
- 2025 vs 2024
- Net income growth
- +127.57%
- 2025 vs 2024
- Net margin
- 65.6%
- 2024: 60.5%
Financial data
Amounts in millions of KRW; per-share values in KRW; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 215,859 | 102,855 | 96,523 | 28,806 | — |
| Cost of revenue | 50,234 | 38,786 | 65,324 | 24,275 | — |
| Gross profit | 165,625 | 64,069 | 31,199 | 4,531 | — |
| Selling, general and administrative | 5,550 | 3,800 | 5,021 | 5,411 | — |
| Research and development | 37,048 | 24,550 | 25,306 | 18,660 | — |
| Operating income | 106,900 | 25,404 | -9,737 | -29,374 | — |
| EBIT | 173,703 | 37,287 | -2,893 | -9,544 | — |
| EBITDA | 179,193 | 40,137 | 440 | -6,890 | — |
| Interest expense | 10,967 | 675 | 671 | 425 | — |
| Pre-tax income | 162,736 | 36,612 | -3,564 | -9,970 | — |
| Income tax | 17,563 | -24,078 | 17.8 | 108 | — |
| Net income | 141,666 | 62,252 | -3,372 | -8,146 | — |
| Net income to common shareholders | 141,666 | 62,252 | -3,372 | -8,146 | — |
| Basic EPS | 2,040.77 | 901.54 | -50.00 | -122.31 | — |
| Diluted EPS | 1,993.08 | 894.62 | -50.00 | -122.31 | — |
| Average shares (basic) | 69.4 | 69.1 | 67.4 | 66.6 | — |
| Average shares (diluted) | 71.1 | 69.6 | 67.4 | 68.8 | — |